T5O.DE
Price:
$0.32
Market Cap:
$164.40K
CytoTools AG, a biotechnology company, develops a pipeline of disease modifying therapies. The company's therapies include proprietary small molecules and biologics to provide treatment options in dermatology, cardiology and angiology, urology, and oncology. Its lead clinical product is DermaPro that has completed Phase III clinical trials for the treatment of diabetic foot ulcers in India; is in Phase III clinical trials for diabetic foot ulcer treatment in Europe; and is in Phase II/III clinical studies for the treatment of venous leg ulcers in Germany, as well as is used as an anti-infective. The company also develops Utisept, an urological medical device for flushing the bladder in urina...[Read more]
Industry
Biotechnology
IPO Date
2006-12-18
Stock Exchange
XETRA
Ticker
T5O.DE
According to CytoTools AG’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of CytoTools AG over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), T5O.DE's Dividend Yield was at its highest in in the June 2009 quarter at 0%. The Dividend Yield was at its lowest in in the June 2009 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of CytoTools AG Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | 0% |
| 2017 | 0% | 0% |
| 2016 | 0% | 0% |
| 2015 | 0% | 0% |
| 2014 | 0% | 0% |
The current Dividend Yield of CytoTools AG (T5O.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
CytoTools AG’s Dividend Yield is less than Biofrontera AG (0%), less than Paion AG (0%), less than FamiCord AG (0%), less than Viscom AG (0%), less than Syzygy AG (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $20.67M | |
| 0% | $2.71M | |
| 0% | $118.54M | |
| 0% | $36.07M | |
| 0% | $21.60M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CytoTools AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like CytoTools AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is CytoTools AG's Dividend Yield?
How is the Dividend Yield calculated for CytoTools AG (T5O.DE)?
What is the highest Dividend Yield for CytoTools AG (T5O.DE)?
What is the 3-year average Dividend Yield for CytoTools AG (T5O.DE)?
What is the 5-year average Dividend Yield for CytoTools AG (T5O.DE)?
How does the current Dividend Yield for CytoTools AG (T5O.DE) compare to its historical average?